Overseas Laws and Regulations and Country Risk
First written in FY2016. 11 of 14 entries say "Materialised", first in FY2020-Q2. Latest entry: FY2026.
Sms moved to the "Worse" side of this theme in 2018, 3 years before the typical company in this theme (2021).
The whole theme swung hardest in 2025: 47 of 94 companies on the "Worse" side.
27 other companies' latest entry also says "Materialised".
- FY2026MaterialisedAnnual report
「In the overseas business, revenue for the fiscal year declined year on year due to the reduction in marketing budgets by some customers in the medical platform business and the impact on healthcare professionals' travel from the deteriorating situation in the Middle East in the global career business, among other factors.」
The reduction in customer budgets and the impact on travel from the deteriorating situation in the Middle East have materialized in the year-on-year revenue decline in the overseas business. - FY2026-H1MaterialisedAnnual report
「The global career business also reported lower revenue year on year, partly because concerns about the situation in the Middle East affected cross-border travel by healthcare professionals. As a result, overseas revenue for the interim consolidated accounting period was ¥3,418 million, down 11.9% year on year.」
The impact on healthcare professionals' travel from concerns about the situation in the Middle East has materialized in the global career business's year-on-year revenue decline. - FY2025MaterialisedAnnual report
「Growth in consolidated net sales for the fiscal year was limited due to the temporary reduction in marketing budgets by some customers in the medical platform business, the temporary suspension of visa issuance in the global career business, and changes in the situation in the Middle East, among other factors.」
Country and institutional risks involving overseas customer budgets, visa issuance and the situation in the Middle East have materialized as limited growth in overseas revenue for the fiscal year. - FY2023MaterialisedAnnual report
「In the overseas business, the medical platform business continued to grow steadily. Although it was temporarily affected by lockdowns in China, the shift to digital accelerated amid the spread of COVID-19, and online events and digital products performed well.」
The company states that lockdowns in China temporarily affected the overseas medical platform business. - FY2023-Q3MaterialisedAnnual report
「In the overseas business, the medical platform business continued to grow steadily. Although it was temporarily affected by lockdowns in China, the shift to digital accelerated amid the spread of COVID-19, and online events and digital products performed well.」
The company continues to state that lockdowns in China temporarily affected the overseas medical platform business, showing that overseas political and social-environment risks also affected the business during the period. - FY2023-Q2MaterialisedAnnual report
「In the overseas business, the medical platform business grew significantly. Although it was temporarily affected by lockdowns in China, the shift to digital accelerated amid the spread of COVID-19, and online events and digital products performed well.」
The company states that lockdowns in China temporarily affected the overseas medical platform business, showing that overseas political and social-environment risks have materialized in the business. - FY2021RestatedAnnual report
「In overseas operations of this kind, events that are difficult to anticipate may occur due to factors including global economic trends, country-specific political, economic and social conditions, laws and regulations, tax systems, differences in culture and business practices, and the natural environment.」
The company has reconfirmed the country risks associated with overseas expansion, including political, economic, social, legal and regulatory, tax, cultural and natural-environment factors, as well as information gathering and countermeasures through its coordinating base. - FY2020-Q3MaterialisedAnnual report
「In the overseas business, MIMS's existing businesses, which provide marketing support and other services to medical and healthcare-related companies, were affected by temporary factors including foreign exchange movements and the Hong Kong protests. In the global career business, in addition to the impact of reorganizing Medilabs, which operates career services for nurses in South Korea, under MIMS in March 2019 and changing the timing of its consolidation, the business was affected by changes to travel authorization procedures for introducing Malaysian healthcare professionals to medical institutions in Saudi Arabia, which lengthened the lead time before travel.」
The company states that foreign exchange movements, the Hong Kong protests, the reorganization of Medilabs and changes to travel authorization procedures affected the overseas business. - FY2020-Q2MaterialisedAnnual report
「In addition to the impact of reorganizing Medilabs, which operates career services for nurses in South Korea, under MIMS in March 2019 and changing the timing of its consolidation, revenue declined year on year because changes to travel authorization procedures for introducing Malaysian healthcare professionals to medical institutions in Saudi Arabia lengthened the lead time before travel.」
In the overseas business, changes to travel authorization procedures lengthened the lead time before travel, resulting in a 3.8% year-on-year decline in overseas revenue. The risks of changes in overseas laws, regulations and systems have materialized in business progress and revenue. - FY2018ReframedAnnual report
「Overseas operations involve various potential risks associated with conducting business in an environment completely different from that in Japan, due to factors that are difficult to predict, including political factors such as legal systems, regulations governing the nursing care and medical sectors, and political instability; economic factors such as foreign exchange rates and economic conditions; cultural factors such as culture and business practices; and the social environment. For overseas expansion, we maintain our coordinating base in Singapore and conduct business while monitoring the country risks of each market in cooperation with our Japanese head office.」
The explanation of overseas legal and regulatory risks has been expanded to cover country risks generally, including political, economic, cultural and social factors. Cooperation between the Singapore coordinating base and the Japanese head office is stated as the response policy. - FY2016First statedAnnual report
「Our overseas subsidiaries are subject to local laws and regulations, which may be strengthened in the future or supplemented by new legal requirements that are not currently anticipated.」
The company categorizes the business risks arising from differences in the political, economic, cultural and social environments from those in Japan as risks associated with overseas expansion.